AffRegInc.i
Curation
Accueil
Racine
Curation
Exploration
Accueil
Racine
Accueil
Racine

Serveur d'exploration Tocilizumab - Curation (Accueil)

Index « AffRegInc.i » - entrée « Kumamoto »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Kuala Lumpur < Kumamoto < Kumamoto  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 14.
Ident.Authors (with country if any)Title
000902 (2019) Shunsuke Mori [Japon] ; Tamami Yoshitama [Japon] ; Yasuyo Abe [Japon] ; Toshihiko Hidaka [Japon] ; Naoyuki Hirakata [Japon] ; Kiyoshi Aoyagi [Japon] ; Yukitaka Ueki [Japon]Retention of tocilizumab with and without methotrexate during maintenance therapy for rheumatoid arthritis: the ACTRA-RI cohort study.
001864 (2017) Shunsuke Mori [Japon] ; Tamami Yoshitama [Japon] ; Toshihiko Hidaka [Japon] ; Fumikazu Sakai [Japon] ; Mizue Hasegawa ; Yayoi Hashiba [Japon] ; Eiichi Suematsu [Japon] ; Hiroshi Tatsukawa [Japon] ; Akinari Mizokami [Japon] ; Shigeru Yoshizawa [Japon] ; Naoyuki Hirakata [Japon] ; Yukitaka Ueki [Japon]Comparative risk of hospitalized infection between biological agents in rheumatoid arthritis patients: A multicenter retrospective cohort study in Japan.
001A30 (2016) Shiho Fujiwara [Japon] ; Hiromi Mochinaga [Japon] ; Hirotomo Nakata [Japon] ; Koichi Ohshima [Japon] ; Masanori Matsumoto [Japon] ; Mitsuhiro Uchiba [Japon] ; Yoshiki Mikami [Japon] ; Hiroyuki Hata [Japon] ; Yutaka Okuno [Japon] ; Hiroaki Mitsuya [Japon] ; Kisato Nosaka [Japon]Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids.
001B66 (2016) Shunsuke Mori [Japon] ; Yukinori Koga [Japon]Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy.
001D39 (2016) Tadashi Nakamura [Japon] ; Tetsuro Yamamoto [Japon]Potential of a 70 kDa IL‐10‐like factor in synovial fluid from rheumatoid arthritis patients to augment superoxide generation by human neutrophils
002047 (2015) Shunsuke Mori [Japon] ; Tamami Yoshitama [Japon] ; Toshihiko Hidaka [Japon] ; Naoyuki Hirakata [Japon] ; Yukitaka Ueki [Japon]Effectiveness and safety of tocilizumab therapy for patients with rheumatoid arthritis and renal insufficiency: a real-life registry study in Japan (the ACTRA-RI study).
002145 (2015) Shunsuke Mori [Japon] ; Mineharu Sugimoto [Japon]Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations
002847 (2013) Shunsuke Mori [Japon] ; Yukitaka Ueki [Japon] ; Yukihiro Akeda [Japon] ; Naoyuki Hirakata [Japon] ; Motohiro Oribe [Japon] ; Yoshiki Shiohira [Japon] ; Toshihiko Hidaka [Japon] ; Kazunori Oishi [Japon]Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy
003565 (2012) Shunsuke Mori [Japon] ; Yukitaka Ueki [Japon] ; Naoyuki Hirakata [Japon] ; Motohiro Oribe [Japon] ; Toshihiko Hidaka [Japon] ; Kazunori Oishi [Japon]Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis
003D88 (2010) Tadashi Nakamura [Japon] ; Syu-Ichi Higashi [Japon] ; Kunihiko Tomoda [Japon] ; Michishi Tsukano [Japon] ; Masahiro Shono [Japon]Etanercept can induce resolution of renal deterioration in patients with amyloid A amyloidosis secondary to rheumatoid arthritis
003D99 (2010) Shunsuke Mori [Japon] ; Jun Hirose [Japon] ; Kensuke Yonemura [Japon]Contribution of HLA-DRB1*04 alleles and anti-cyclic citrullinated antibodies to development of resistance to disease-modifying antirheumatic drugs in early rheumatoid arthritis
003F21 (2009) Satoru Shinriki [Japon] ; Hirofumi Jono ; Kazutoshi Ota ; Mitsuharu Ueda ; Mareina Kudo ; Tomoko Ota ; Yuichi Oike ; Motoyoshi Endo ; Mutsuko Ibusuki ; Akimitsu Hiraki ; Hideki Nakayama ; Yoshihiro Yoshitake ; Masanori Shinohara ; Yukio AndoHumanized anti-interleukin-6 receptor antibody suppresses tumor angiogenesis and in vivo growth of human oral squamous cell carcinoma.
004048 (2009) Satoru Shinriki [Japon] ; Hirofumi Jono [Japon] ; Kazutoshi Ota [Japon] ; Mitsuharu Ueda [Japon] ; Mareina Kudo [Japon] ; Tomoko Ota [Japon] ; Yuichi Oike [Japon] ; Motoyoshi Endo [Japon] ; Mutsuko Ibusuki [Japon] ; Akimitsu Hiraki [Japon] ; Hideki Nakayama [Japon] ; Yoshihiro Yoshitake [Japon] ; Masanori Shinohara [Japon] ; Yukio Ando [Japon]Humanized Anti-interieukin-6 Receptor Antibody Suppresses Tumor Angiogenesis and In vivo Growth of Human Oral Squamous Cell Carcinoma
004050 (2009) Mareina Kudo [Japon] ; Hirofumi Jono [Japon] ; Satoru Shinriki [Japon] ; Shigetoshi Yano [Japon] ; Hideo Nakamura [Japon] ; Keishi Makino [Japon] ; Takuichiro Hide [Japon] ; Daisuke Muta [Japon] ; Mitsuharu Ueda [Japon] ; Kazutoshi Ota [Japon] ; Yukio Ando [Japon] ; Jun-Ichi Kuratsu [Japon]Antitumor effect of humanized anti-interleukin-6 receptor antibody (tocilizumab) on glioma cell proliferation: Laboratory investigation

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/AffRegInc.i -k "Kumamoto" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/AffRegInc.i  \
                -Sk "Kumamoto" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Curation
   |type=    indexItem
   |index=    AffRegInc.i
   |clé=    Kumamoto
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021